EMA Authorised: Verzenios (abemaciclib) — Eli Lilly Nederland B.V.

View source ↗

Summary

Authorised status for Verzenios (abemaciclib) in the EU for treatment of breast neoplasms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Neoplasms

Drugs mentioned

• Verzenios (abemaciclib)

Snippet

Status: Authorised. Therapeutic area: Breast Neoplasms. MAH: Eli Lilly Nederland B.V.. Decision date: 25/08/2026